Authors: Ballard, Clive¹; Day, Sarah²; Sharp, Sally³; Wing, Gayle²; Sorensen, Susanne²

Source: International Review of Psychiatry, Volume 20, Number 4, August 2008 , pp. 396-404(9)

Publisher: Informa Healthcare

Abstract:

Neuropsychiatric symptoms are frequent in people with dementia, result in distress for the people experiencing them and their caregivers, and are a common precipitant of institutional care. The safe and effective treatment of these symptoms is a key clinical priority, but is a long way from being achieved. Psychological interventions are recommended as the first line treatment strategy in most good practice guidelines, and there is emerging evidence of efficacy for agitation and depression. Neuroleptics remain the mainstay of pharmacological treatment, although meta-analyses indicate that they are mainly of benefit for the short-term (up to 12 weeks) treatment of aggression in people with Alzheimer's disease, and there have been increasing concerns about serious adverse effects including mortality. The evidence is limited for other pharmacological approaches for the treatment of agitation, and psychosis in people with Alzheimer's disease is limited, but post-hoc analyses do indicate that memantine may be a promising therapy and aromatherapy may be a useful alternative. Autopsy studies indicate that the adrenergic system may be an important therapeutic target. Clinical experience suggests that antidepressants are effective in people with severe depression in the context of dementia, but the evidence base regarding the broader value of antidepressants is far from clear. There are very few trials specifically focusing upon the treatment of neuropsychiatric symptoms in common non-Alzheimer dementias, which is a major limitation and urgently needs to be addressed to provide an evidence base to enable the safe and effective treatment of these individuals.

Document Type: Research article

DOI: http://dx.doi.org/10.1080/09540260802099968

Affiliations: 1: Wolfson Centre for Age-Related Diseases, Guy's Campus, King's College London,Alzheimer's Society, London, UK 2: Alzheimer's Society, London, UK 3: Wolfson Centre for Age-Related Diseases, Guy's Campus, King's College London,

Publication date: 2008-08-01

More about this publication?

• Information for Authors
• Subscribe to this Title
• Terms & Conditions
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• In this Subject: Neurology & Psychiatry
• By this author: Ballard, Clive ;  Day, Sarah ;  Sharp, Sally ;  Wing, Gayle ;  Sorensen, Susanne

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers